ImMage Biotherapeutics

Founded in May 2015, ImMAGE Biotherapeutics Corp. is a seed-funded biotechnology company developing the first universal Immunotherapy to treat patients with an aggressive form of breast cancer called Triple NegativeBreast Cancer (TNBC).

Website :

Call 2017

Call for applications open.




Receive notifications about the YEi Start in France program (Call for applications, announcement of the laureates, YEi events, etc.)

Social Links